Tag - FishFarmingExpert.com

Skip to main content

FishFarmingExpert

Customer Service

Categories

Subscribe

Close main menu

CleanTreat helps drive ‘excellent’ six months for Benchmark

CleanTreat helps drive ‘excellent’ six months for Benchmark

Aquaculture health, genetics and nutrition company Benchmark Holdings has reported ‘excellent’ interim results for the first half of 2022, with 33% growth in revenues to £79.2 million and 100% growth in earnings to £15.9 million before interest and tax.

Benchmark gets go-ahead for double use of Ectosan baths

Benchmark gets go-ahead for double use of Ectosan baths

Aquaculture biotechnology company Benchmark has been granted permission to re-use the treatment water for its novel Ectosan Vet lice treatment for a second batch of fish.

CleanTreat to be trialled by Mowi in Scotland

CleanTreat to be trialled by Mowi in Scotland

Aquaculture biotechnology company Benchmark’s lice treatment water purification system CleanTreat will be tested at a Mowi fish farm in Scotland over the next month, in a trial supported by the University of Stirling’s Institute of Aquaculture and the Sustainable Aquaculture Innovation Centre (SAIC).

Award nomination 'is a recognition for lice treatment efforts'

Award nomination 'is a recognition for lice treatment efforts'

The head of Benchmark Animal Health, John Marshall, has expressed his delight that the business has been shortlisted in the Aquaculture Awards, which will be presented at Aquaculture UK at Aviemore in May.

Benchmark orders third CleanTreat unit

Benchmark orders third CleanTreat unit

Aquaculture biotechnology company Benchmark Holdings has ordered a third CleanTreat filtration system for use with its novel lice treatment Ectosan Vet.

Benchmark strengthens lice treatment support team

Benchmark strengthens lice treatment support team

UK-headquartered aquaculture biotechnology company Benchmark Holdings has strengthened its Norway team to support the roll-out of its combined Ectosan Vet / CleanTreat sea lice bath treatment and water filtration unit.

Benchmark raises £20.7m for headroom and investment

Benchmark raises £20.7m for headroom and investment

Aquaculture health, genetics and nutrition company Benchmark today said it had raised £20.7 million through a placing of more than 33 million new shares with existing and new investors.

Benchmark reduces losses as revenues rise

Benchmark reduces losses as revenues rise

Aquaculture health, genetics and nutrition company Benchmark increased revenue and adjusted EBITDA by 18% and 34% respectively in its 2021 financial year, reducing pre-tax losses to £9.2 million from £22.6m last year.

Full-year results will be better than market expects, says Benchmark

Full-year results will be better than market expects, says Benchmark

Aquaculture health, genetics and nutrition company Benchmark Holdings today said it expected full-year results to be significantly ahead of the current market consensus of £15.9 million.

CleanTreat wins seal of approval from Aquaculture Stewardship Council

CleanTreat wins seal of approval from Aquaculture Stewardship Council

Aquaculture biotechnology company Benchmark Holdings today announced today that it has received the highest level of recognition for environmental protection and sustainability from certification body the Aquaculture Stewardship Council (ASC).

First CleanTreat vessel ready to start work in Norway

First CleanTreat vessel ready to start work in Norway

A vessel equipped with Benchmark’s proprietary CleanTreat filtration system has arrived in Norway ahead of its first commercial deployment.

Novel lice treatment gets green light for use in Norway

Novel lice treatment gets green light for use in Norway

The novel salmon lice treatment Ectosan Vet has been approved for use in Norway, its developer, Benchmark Holdings, announced today.

New lice treatment wins Norway marketing authorisation

New lice treatment wins Norway marketing authorisation

Aquaculture biotechnology company Benchmark today announced that is had received marketing authorisation from the Norwegian Medicines Agency (NoMA) for its novel lice treatment Ectosan Vet (BMK08) in Norway.

EU setback for novel lice treatment

EU setback for novel lice treatment

A doubt has been cast over the commercial introduction of Benchmark’s novel sea lice treatment BMK08 after the European Parliament backed a blocking move by a Green MEP.

Previous
1 (current)
2
3
Next